Cross-clade cytotoxic t cell response to human immunodeficiency virus type 1 proteins among HLA disparate North Americans and Thais

59Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A globally effective vaccine will need to elicit cytotoxic T lymphocytes (CTL) capable of recognizing diverse human immunodeficiency virus type 1 (HIV-1) clades. Study of the cellular immune responses of HIV-1-infected persons may allow predictions to be made regarding useful vaccine antigen components. The frequency and magnitude of CTL responses to clade E and B Gag, Pol-RT, Env, and Nef proteins were compared in 12 HLA-characterized, clade E-infected Thais and in 10 clade B-infected North Americans using vaccinia recombinant constructs for protein expression. While responses were detected against all proteins, they were most frequent and cross-reactive to Gag in both groups. PoI-RT was recognized less frequently in Thais than North Americans. Cross-clade protein recognition was common but not uniformly present among these HLA-disparate individuals. Population-specific CTL data are needed to adequately prepare for vaccine trials outside of North America and Europe.

Cite

CITATION STYLE

APA

Lynch, J. A., Desouza, M., Robb, M. D., Markowitz, L., Nitayaphan, S., Sapan, C. V., … Cox, J. H. (1998). Cross-clade cytotoxic t cell response to human immunodeficiency virus type 1 proteins among HLA disparate North Americans and Thais. Journal of Infectious Diseases, 178(4), 1040–1046. https://doi.org/10.1086/515652

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free